1. 1194PTranslational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A). (23rd October 2018) Authors: Diamond, J R; Standifer, N; Ascierto, M L; Morehouse, C; Ghadially, H; Rodriguez Canales, J; Rebelatto, M C; Naidoo, J; Mazzarella, L; Patel, S; Flor Oncala, M J; Alonso Gordoa, T; Wang, D; Song, X; Jones, D C; Li, X; Marshall, S; Abdullah, S; Jure-Kunkel, M; Hellmann, M D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 411OInitial results from a phase I/IIa trial evaluating BMS-986158, an inhibitor of the bromodomain and extra-terminal (BET) proteins, in patients (pts) with advanced cancer. (23rd October 2018) Authors: Hilton, J; Cristea, M C; Voskoboynik, M; Postel-Vinay, S; Edenfield, W; Gavai, A; Wee, S; Srivastava, N; Klippel, A; Jackson, D; Apfel, A; Chasalow, S D; Williams, D; Donovan, M; Fischer, B; Khaldoyanidi, S; Diamond, J R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗